Lanthanide Metallacrown Complexes for NIR Necrotic Cell Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid-binding NIR dyes for optical imaging suffer from low quantum yield, broad bandwidth, high energy excitation wavelengths, small Stokes shift, poor water solubility, and low photostability, limiting detection sensitivity and image resolution, while quantum dots face issues like blinking and toxicity for in vivo applications.

Innovation Solution

Development of lanthanide-based metallacrown complexes, specifically Ln(III)Zn16(HA ligand)16 complexes where the HA ligand is a hydroximate, which exhibit high quantum yields, long luminescence lifetimes, and resistance to photobleaching, used for simultaneous cell fixation and staining, enabling effective NIR and visible staining of necrotic cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If nucleic acid-binding NIR dyes are used for optical imaging, then imaging capability is achieved, but detection sensitivity and image resolution deteriorate due to low quantum yield, broad bandwidth, and poor photostability

Engineering Contradiction:
Improvedetection sensitivity and image resolutionVSAvoidquantum yield and photostability
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent changes the fundamental parameters of the imaging agent by transitioning from organic fluorophores to lanthanide-based metallacrown complexes. This substitution fundamentally alters the optical properties, achieving narrow bandwidth, high quantum yield, and enhanced photostability through the unique 4f electron configuration of lanthanide ions, which provides sharp emission lines and resistance to photobleaching

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite materials by combining lanthanide ions with metallacrown complexes. This composite structure integrates the photostable lanthanide core with the stabilizing metallacrown ligand framework, creating a hybrid material that exhibits both high quantum yield and exceptional photostability while maintaining water solubility through hydrophilic ligand design

Inventive Principle:
Principle #40Composite materials

2Reliability

If quantum dots are used for imaging, then photobleaching resistance and quantum yield improve, but toxicity and blinking occur affecting in vivo applications

Engineering Contradiction:
Improvephotobleaching resistance and quantum yieldVSAvoidtoxicity and blinking
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces persistent quantum dots with biodegradable metallacrown complexes that can be safely eliminated from biological systems. The metallacrown structures are designed to be metabolically stable yet ultimately decomposable, avoiding the accumulation and long-term toxicity associated with quantum dots while maintaining their superior optical properties

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the material composition from semiconductor quantum dots to lanthanide-based complexes, fundamentally altering the emission mechanism from band-gap transitions to 4f-4f electron transitions. This parameter change eliminates blinking phenomena and reduces toxicity while preserving high quantum yield and photobleaching resistance

Inventive Principle:
Principle #35Parameter changes

3Productivity

If conventional staining methods are used, then cell staining is achieved, but simultaneous cell fixation and morphology preservation are not accomplished

Engineering Contradiction:
Improvestaining efficiencyVSAvoidnumber of steps
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent merges the staining function with the fixation function into a single integrated process. The metallacrown complexes serve dual purposes: they bind to and stain cellular components while simultaneously cross-linking proteins to fix the cell structure. This consolidation eliminates separate fixation and staining steps, reducing procedural complexity while preserving morphology and enabling subsequent imaging

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent creates a universal reagent that performs multiple functions simultaneously. The metallacrown complexes exhibit multi-functionality by acting as both stains and fixatives, and additionally serving as photostable imaging probes. This single agent replaces multiple conventional reagents, streamlining the workflow while achieving comprehensive cell preservation and visualization

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The lanthanide-based metallacrown complexes provide intense near-infrared luminescence, high sensitivity, and stability, effectively staining and fixing cells, preserving morphology and allowing for sensitive detection of necrotic cells with improved photostability and reduced toxicity.

Implementation Method 1

Ln(III)Zn16(HA ligand)16 complexes... exhibit high quantum yields, long luminescence lifetimes, and resistance to photobleaching

Methodology Applied
Scientific EffectLuminescence: Luminescence

Implementation Method 2

provide intense near-infrared luminescence... enabling effective NIR and visible staining of necrotic cells

Methodology Applied
Scientific EffectPhotoluminescence: Photoluminescence

Implementation Method 3

Ln(III)Zn16(HA ligand)16 complexes where the HA ligand is a hydroximate... simultaneously cell fixation and staining

Methodology Applied
Scientific EffectCoordination bonding: Chemical Bonding

Data Source

PatentUS11408893B2Selective near-infrared optical imaging of necrotic cells and simultaneous cell fixing and counter staining with metallacrown complexes
Publication Date: 2022.08.09 THE RGT UNIV OF MICHIGAN
  • US11408893B2 patent drawing
  • US11408893B2 patent drawing
  • US11408893B2 patent drawing

AI summary

A method for selective labelling of necrotic cells including incubating the cells in a solution including a Ln(III)Zn16(HA ligand)16 metallacrown complex, wherein the HA ligand is a hydroximate ligand.